Ken Mariash, Sinaptica Therapeutics - Spotlight Studio | LSI Europe '23

Sinaptica Therapeutics is a clinical-stage company that is developing a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease.
Speakers
Ken Mariash
Ken Mariash
CEO, Sinaptica Therapeutics